Literature DB >> 19521669

Early preconditioning protection against stunning in conscious sheep. Role of KATP channels.

Elena Catalina Lascano1, Jorge A Negroni, Héctor F del Valle.   

Abstract

The aim of this study was to assess early preconditioning protection against stunning in conscious sheep and analyze the role of ATP-dependent potassium (KATP) channels in the protective mechanism. Chronically instrumented animals were submitted to a 12 min reversible ischemia and 2 h reperfusion. Early preconditioning, consisting of six 5 min occlusion-5 min reperfusion periods, followed by 45 min normoperfusion before the prolonged ischemia protected against stunning (P < 0.01). In these experimental conditions, current agents used to analyze sarcolemmal (sKATP) and mitochondrial (mKATP) KATP channels could not clearly establish their participation in the protective mechanism. At doses that inhibit sKATP channels they were unable to block preconditioning protection against stunning (glibenclamide) or conversely, blocked preconditioning at doses that do not inhibit these channels (HMR1098). Moreover, both mKATP channel agonists (diazoxide) and antagonists (5HD) protected against stunning, a response that could be due to their effect via an alternative mitochondrial pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521669     DOI: 10.1007/s11010-009-0166-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  46 in total

1.  Preconditioning does not attenuate myocardial stunning.

Authors:  M Ovize; K Przyklenk; S L Hale; R A Kloner
Journal:  Circulation       Date:  1992-06       Impact factor: 29.690

2.  ATP-sensitive potassium channels do not have a main role in mediating late preconditioning protection against arrhythmias and stunning in conscious sheep.

Authors:  Jorge A Negroni; Elena C Lascano; Héctor F del Valle; Alberto J Crottogini
Journal:  Basic Res Cardiol       Date:  2002-01       Impact factor: 17.165

3.  Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.

Authors:  T Pain; X M Yang; S D Critz; Y Yue; A Nakano; G S Liu; G Heusch; M V Cohen; J M Downey
Journal:  Circ Res       Date:  2000-09-15       Impact factor: 17.367

Review 4.  Glibenclamide action on myocardial function and arrhythmia incidence in the healthy and diabetic heart.

Authors:  J A Negroni; E C Lascano; H F del Valle
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

5.  The K(ATP) channel blocker HMR 1883 does not abolish the benefit of ischemic preconditioning on myocardial infarct mass in anesthetized rabbits.

Authors:  O Jung; H C Englert; W Jung; H Gögelein; B A Schölkens; A E Busch; W Linz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-04       Impact factor: 3.000

6.  The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.

Authors:  G J Grover; S Dzwonczyk; P G Sleph; C A Sargent
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

7.  Preconditioning improves energy metabolism during reperfusion but does not attenuate myocardial stunning in porcine hearts.

Authors:  M Miyamae; H Fujiwara; M Kida; R Yokota; M Tanaka; M Katsuragawa; K Hasegawa; M Ohura; K Koga; Y Yabuuchi
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

Review 8.  Nitric oxide in myocardial ischemia/reperfusion injury.

Authors:  Rainer Schulz; Malte Kelm; Gerd Heusch
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

9.  Ischemic preconditioning targets the reperfusion phase.

Authors:  Derek J Hausenloy; Abigail M Wynne; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2007-05-29       Impact factor: 17.165

10.  Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

Authors:  G J Gross; J A Auchampach
Journal:  Circ Res       Date:  1992-02       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.